A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
This clinical drug-drug interaction study is being conducted to evaluate the pharmacokinetics of dacarbazine(DTIC) when administered in combination with Genasense
Advanced Melanoma
DRUG: GenasenseÂ® (G3139, oblimersen sodium)|DRUG: Genasense followed by DTIC; then DTIC alone|DRUG: DTIC alone; then Genasense followed by DTIC
This clinical drug-drug interaction study is being conducted to evaluate the pharmacokinetics of dacarbazine(DTIC) when administered in combination with Genasense